newsfilter
← Latest News
GlobeNewswire·

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

CORAL GABLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing,